Russia To Supply 17 More Countries With COVID-19 Drug Avifavir

MOSCOW: Russia’s sovereign wealth fund and its partner Chemrar will supply the COVID-19 drug Avifavir to 17 additional countries, the fund said in a statement on Thursday.

Avifavir gained approval from the Russian health ministry in May and is based on favipiravir, which was developed in Japan and is widely used there as the basis for viral treatments.


Clinical trials in Japan and Russia have confirmed those drugs’ efficacy, the Russian Direct Investment Fund (RDIF) said in a statement.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor


Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Who Pays For The Toilet Paper? The Big Questions...

AMSTERDAM: As the world convulses in crisis, and tens of millions of us dig...

The 30 Most Popular Online Courses of 2020

How to Learn Online from edX. "Learn essential strategies for successful online learning." Excel/VBA for...

AMC’s Blacklisting Of Universal Is Either A Bluff Or...

Ramsey (Nathalie Emmanuel) and Dom (Vin Diesel) in F9,...

Council Post: Five Areas Where AI Is Revolutionizing The...

CEO, Healr Solutions & Center for Public Leadership Fellow, Harvard Kennedy School. With the increasing...